GovSat-1 Successfully Launched on SpaceX Falcon 9 Rocket
The GovSat-1 spacecraft was successfully launched into space today on board a flight-proven SpaceX Falcon 9 rocket at 4:25 PM EST from Cape Canaveral Air Force Station.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180131006438/en/
GovSat-1 Successfully Launched on SpaceX Falcon 9 Rocket (Photo: SpaceX)
GovSat-1 is the first satellite of GovSat, a public private partnership between the Government of Luxembourg and the world-leading satellite operator SES.
The multi-mission satellite will be located at the 21.5 degrees East orbital slot, to serve governmental and institutional customers over Europe, the Middle East and Africa, and provide extensive maritime coverage over the Mediterranean and Baltic seas, and the Atlantic and Indian oceans.
The highly flexible and resilient GovSat-1 payload features advanced security capabilities and uses dedicated frequencies in X-band and military Ka-band. GovSat-1 is equipped with six high-powered fully steerable spot beams, a high-power X-band Global beam, and features sixty-eight transponder equivalent units in total.
The satellite is entirely dedicated to government and institutional users, and will be operated by GovSat from the Secure Mission Operations Centre in Luxembourg. The secure and robust connectivity on GovSat-1 will enable critical communications in theatres of operations, interconnect key institutional or defence sites, and support applications such as Intelligence, Surveillance and Reconnaissance (ISR) and communications on the move, among others.
The Luxembourg Government has pre-committed an important amount of capacity on the satellite in support of its NATO commitments. The remaining capacity will be made available to governmental and institutional users on commercial business terms.
“The launch of GovSat-1 opens up a new era of secure satellite connectivity for governments and institutions," said Patrick Biewer, Chief Executive Officer of GovSat. “It brings differentiated capabilities on secure X- and military Ka-band, leveraging private sector efficiencies and strong governmental support. GovSat-1 was designed to meet the specific needs of government customers, and will enable a wide array of defence and civilian security applications, even in the most remote locations.”
Xavier Bettel, Prime Minister of Luxembourg, said, “Luxembourg has always been a pioneer in the space industry and has a long tradition in innovative partnerships with private aerospace companies. The launch of GovSat-1 is the beginning of a new space experience for Luxembourg, after the foundation of SES in 1985 and the launch of the first SES satellite nearly 30 years ago. GovSat and the launch of GovSat-1 is another step towards strengthening the position of Luxembourg as a key player in the aerospace sector, and contributes to a diversification of our economy.”
Etienne Schneider, Deputy Prime Minister and the Minister of the Economy, said, “Luxembourg has delivered on our pledge to increase our defence spending as a NATO ally in line with our defence commitments. We are doing this through an innovative partnership with the Luxembourg based leading satellite operator SES. We are thus providing an efficient and reliable solution for satellite communications that meets the increasingly sophisticated demands of our NATO allies. We are leveraging the competences of the Luxembourg space industry, which enjoys a great reputation worldwide and is further being developed through Luxembourg's SpaceResources.lu initiative.”
Karim Michel Sabbagh, President and CEO of SES, said, “Global government satellite communications is an important growth driver for SES, and we continue to expand our capabilities to serve this thriving market. The GovSat-1 satellite brings differentiated capabilities which complement SES’s existing suite of offerings for governments and institutions. This unique solution is possible thanks to our partnership with the Luxembourg Government.”
The spacecraft was built by Orbital ATK and is based on the GEOStar-3™ satellite platform. It is Orbital ATK’s 40th GEOStar satellite.
Check the GovSat-1 Newsroom here
Follow us on:
GovSat is a public-private partnership between the Government of Luxembourg and the world-leading satellite operator SES. GovSat’s mission is to provide secure, reliable and accessible governmental satellite communication services to address the demand resulting from defence and institutional security applications. The company’s first satellite GovSat-1 is a multi-mission satellite that will use X-band and Military Ka-band frequencies on high-power and fully steerable mission beams to support multiple operations. For more information visit: www.govsat.lu
For further information please contact:
Markus Payer, +352 710 725 500
Corporate Communications & PR
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Game of Thrones Winter is Coming™ Launches Worldwide26.3.2019 02:00:00 EET | Tiedote
Yoozoo Games, a leading game developer and publisher, today announced the global launch of Game of Thrones Winter is Coming™ , a real-time strategy PC browser game officially licensed by Warner Bros. Interactive Entertainment under license from HBO®. The game is now available in English, with additional languages to follow. HBO, Warner Bros. Interactive Entertainment and Yoozoo Games have collaborated to recreate Westeros on a massive scale, delivering an authentic and immersive multiplayer world laid out across the Seven Kingdoms – complete with major landmarks and castles from the epic TV series. The story begins immediately following the death of Eddard Stark, when the player emerges as a new Westeros lord or lady in his stead. Strategising starts in earnest in Game of Thrones Winter is Coming as players aim to build an impenetrable base, train a victorious army and recruit faithful followers from a pool of iconic characters. As players progress, they must continue to acquire the mi
Earth Networks Announces Completion of Severe Weather Early Warning System for PAGASA26.3.2019 02:00:00 EET | Tiedote
Earth Networks announced today the completion of the Philippines’ first nationwide severe weather monitoring and alerting network with associated software services for the Philippine Atmospheric, Geophysical, and Astronomical Services Administration (PAGASA), the National Meteorological and Hydrological Services (NMHS) agency of the Republic of the Philippines. The announcement was made at the 6th annual InterMET Asia conference in Singapore. Initiated in 2017, and formally commissioned this week, the technology partnership between PAGASA and Earth Networks is the first of its kind in the Philippines and surrounding regions, powered by a network of total lightning sensors and real-time automatic weather stations for mesoscale monitoring. Installed and operated together with Philippines partner West Point Engineering, the 10-year program includes: Real-time lightning detection powered by the Earth Networks Total Lightning Network On-the-ground weather monitoring via the Earth Networks W
bluebird bio Statement on European Regulatory Status of LentiGlobin™26.3.2019 01:40:00 EET | Tiedote
A third party press release was issued today stating that the EMA (European Medicines Agency) issued an approval for the conditional Marketing Authorization Application (MAA) for LentiGlobin™, bluebird bio’s investigational gene therapy for the treatment of transfusion dependent β-thalassemia (TDT). LentiGlobin for TDT is scheduled to be reviewed as part of the CHMP (Committee on Human Medicinal Products) meeting from March 25 – 28, however no opinion has been issued by the CHMP. If the CHMP’s opinion is issued it would then be reviewed by the European Commission (EC), which has the authority to grant approval for the use of LentiGlobin in the EU. About bluebird bio, Inc. bluebird bio is pioneering gene therapy with purpose. From our Cambridge, Mass., headquarters, we’re developing gene therapies for severe genetic diseases and cancer, with the goal that people facing potentially fatal conditions with limited treatment options can live their lives fully. Beyond our labs, we’re working
Celgene Submits Application to FDA for Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis25.3.2019 23:30:00 EET | Tiedote
Celgene Corporation (NASDAQ:CELG) today announced that the Company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for ozanimod for the treatment of adults with relapsing forms of multiple sclerosis (RMS). Ozanimod is an oral, sphingosine 1-phosphate (S1P) receptor modulator, which binds with high affinity selectively to S1P subtypes 1 (S1P1) and 5 (S1P5). The pivotal efficacy and safety data provided in the application result from the SUNBEAM™ and RADIANCE™ Part B phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled trials. “New oral treatment options with differentiated profiles like ozanimod are needed to help address an unmet need for people with relapsing forms of MS,” said Jay Backstrom, M.D., Chief Medical Officer for Celgene. “With concurrent applications in the U.S. and EU, we look forward to advancing this promising medicine through the regulatory review process to provide a new option for the treatment of RMS in
AVLT and UKTS Announce the European Medicines Agency’s Approval of the Conditional Marketing Authorization Application for Zynteglo™ (Previously Known as Lentiglobin™) Gene Therapy for the Treatment of Transfusion Dependent Beta Thalassaemia25.3.2019 22:50:00 EET | Tiedote
Associazione Veneta Lotta alla Talassemia (AVLT) and the UK Thalassaemia Society (UKTS) announced today that the European Medicines Agency (EMA) has approved bluebird bio’s application for Conditional Marketing Authorization (cMAA) of their product Zynteglo™, a gene therapy for the treatment of adolescents and adults with transfusion-dependent β-thalassaemia (TDT) who do not have a β0/β0 genotype. As a result of this marketing authorisation, Zynteglo™ is now approved for use in all European countries covered by the European Medicines Agency. Zynteglo™ has been given ‘conditional authorisation’. This means that there is more evidence to be submitted, which the company is required to provide under specific obligations. Every year, the EMA will review any new information that becomes available. “People living with transfusion-dependent β-thalassaemia have a reduced life expectancy, requiring life-long frequent blood transfusions that are life-saving but may lead to complications, includin
Historic Partnership between the Weizmann Institute of Science and Institut Curie25.3.2019 19:54:00 EET | Tiedote
On March 22, the Weizmann Institute of Science in Rehovot, Israel, and Institut Curie in Paris, France, two major world-class research institutes, signed an historic partnership that will allow their teams to work closely together to improve knowledge in the field of life sciences, particularly in the areas of physics and chemistry, and most specifically - in the field of cancer research. This is a milestone in the history of these two institutes that have been working together for 15 years, particularly in the field of biophysics. Collaborative research programs This partnership will extend to many disciplines, including physics, chemistry, cellular biology, epigenetics, genetics, immunology and single cell approaches, imagery and data collection. The complementarity of the research between the various groups at Institut Curie and at the Weizmann Institute has been recognized in particular at the occasion of joint scientific workshops held regularly alternatively in Paris and Rehovot.
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme